Taysha Gene Therapies Announces $200 Million Equity Offering; Shares Drop After Hours
Taysha Gene Therapies said it has begun an underwritten public offering of common stock and pre-funded warrants totaling $200 million, a move that coincided with an 8.5% decline in the company's shares in after-hours trading. The company intends to give underwriters a 30-day option to buy up to an additional 15% of the shares, and the offering rema…